International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Mar 28, 2025, after the close
10-K filed Mar 28, 2025, 87 days after period end · 0000950170-25-046745
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.45M | $1.89M | $2.43M | $1.84M |
| Net Income | $11.00K | -$458.00K |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| $23.00K |
| -$351.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
